Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ichikawa

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Distinct gene expression-defined classes of gastrointestinal stromal tumorUmio Yamaguchi, Robert Nakayama, Kazufumi Honda, et al.
Pancreas|January 19, 2017
Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic CancerHideyuki Hayashi, Takashi Kohno, Hideki Ueno, et al.
Journal of Translational Medicine|October 17, 2025
IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancerChie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)Yu-Chien Kao, Akihiko Yoshida, Tsung-Han Hsieh, et al.
Cell Reports|April 15, 2014
TSPAN2 is involved in cell invasion and motility during lung cancer progressionChihiro Otsubo, Ryo Otomo, Makoto Miyazaki, et al.
Oncotarget|January 19, 2017
Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcomaNaofumi Asano, Akihiko Yoshida, Sachiyo Mitani, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2025
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907)Yuki Kojima, Keisuke Watanabe, Motoko Arakaki, et al.
Genes, Chromosomes & Cancer|May 1, 2013
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaNorio Shiba, Hitoshi Ichikawa, Tomohiko Taki, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
British Journal of Haematology|March 18, 2014
ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in childrenKenichiro Kobayashi, Kazumasa Mitsui, Hitoshi Ichikawa, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Distinct gene expression-defined classes of gastrointestinal stromal tumorUmio Yamaguchi, Robert Nakayama, Kazufumi Honda, et al.
Pancreas|January 19, 2017
Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic CancerHideyuki Hayashi, Takashi Kohno, Hideki Ueno, et al.
Journal of Translational Medicine|October 17, 2025
IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancerChie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)Yu-Chien Kao, Akihiko Yoshida, Tsung-Han Hsieh, et al.
Cell Reports|April 15, 2014
TSPAN2 is involved in cell invasion and motility during lung cancer progressionChihiro Otsubo, Ryo Otomo, Makoto Miyazaki, et al.
Oncotarget|January 19, 2017
Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcomaNaofumi Asano, Akihiko Yoshida, Sachiyo Mitani, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2025
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907)Yuki Kojima, Keisuke Watanabe, Motoko Arakaki, et al.
Genes, Chromosomes & Cancer|May 1, 2013
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaNorio Shiba, Hitoshi Ichikawa, Tomohiko Taki, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
British Journal of Haematology|March 18, 2014
ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in childrenKenichiro Kobayashi, Kazumasa Mitsui, Hitoshi Ichikawa, et al.
Pageof 17